<DOC>
	<DOCNO>NCT01467154</DOCNO>
	<brief_summary>The aim present study determine whether high dose intravenous NAC efficient prevent CN emergency contrast injection patient renal failure .</brief_summary>
	<brief_title>Evaluation Intravenous N-acetylcysteine Prevent Contrast Media Induced Nephrotoxicity Emergency Center</brief_title>
	<detailed_description>Prevention acute kidney injury ( AKI ) post contrast injection remain mandatory give association morbidity mortality1 . Contrast nephropathy ( CN ) classically define increase 25 % absolute increase 44 umol/l creatinine level within three day follow contrast injection2 . Markers cystatine C may sensitive identify CN also correlate mortality8 although definition CN use marker lack . In patient undergo elective radiological procedure , CN prevent hydration , withdrawal diuretic nephrotoxic drug . N Acetylcysteine ( NAC ) propose protect contrast nephropathy since 200013 . While hydratation clearly beneficial prevent CIN14 , role NAC administration still uncertain result RCTs give conflict result regard effect15 . Intravenous N-acetylcysteine ( NAC ) may form choice emergency procedure give rapid disponibility ease administration patient whose consciousness alter eat . The aim present study therefore determine whether 6000 mg intravenous NAC efficient prevent CN emergency contrast injection CKD patient . Inclusion criterion : One hundred thirty consecutive patient estimate GFR &lt; 60 mL/min indication undergo emergent contrast-enhanced CT include study . Exclusion criterion : asthma , pregnancy , obstructive nephropathy patient family 's refusal . Patients blindly randomize computer either placebo ( 0.45 % saline ) high dose ( 6000 mg ) iv n-acétylcystéine ( flumicil ) iv dilute 0.45 % saline . All patient receive intravenous hydration ( 250 ml NaCl 0.45 % least ) CT scan 1000 ml examination depend clinical possibility . Creatinine cystatine C serum level collect one hour CT scan day 2 , 4 10 . The T0 value value measure CT-scan baseline admission value order correct differential hydratation due different wait time hydratation tomography . Serum Creatinine Cystatine C measure Jaffe method , nephelometric assay respectively . Outcome measure : The primary endpoint study occurrence contrast nephropathy day 2 , 4 10 , define increase least 25 % and/or 44 umol/l serum creatinine level cystatine C level day 2 , 4 10 compare day 0 . We also assess proportion patient contrast nephropathy regard biomarker use accord AKIN criterion well . D The AKIN criterion define stage 1 AKI increase creatinine 150 % 199 % baseline absolute increase least 26.2 umol/l , stage 2 AKI increase 200 % 299 % baseline stage 3 AKI increase least 300 % baseline creatinine concentration high 354 umol/l acute rise least 44 umol/l initiation RRT . Secondary endpoint mean increase creatinine cystatin C concentration day 2 , 4 10 maximum increase time period day 2 day 10 ( peak increase ) .</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Renal failure need contrast enhanced CT Asthma Pregnancy Obstructive nephropathy Patient family 's refusal In patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>